Riverpoint Pharmacy (First Pharma Associates LLC), Spokane, WA

Is Riverpoint Pharmacy (First Pharma Associates LLC) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Riverpoint Pharmacy (First Pharma Associates LLC) hold a Washington pharmacy license?

State board of pharmacy records for Washington are not checked: the Department of Health’s open dataset on data.wa.gov lists individual credentials but not pharmacy licenses, and its enforcement column has been removed for now; the department’s provider search is an interactive search, which this index does not use. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054019558 for FIRST PHARMA ASSOCIATES LLC, SPOKANE, WA, status NOT RENEWED, as of Nov 13, 2026.

Has Riverpoint Pharmacy (First Pharma Associates LLC) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Sep 13, 2021), 1 state referral letter (Sep 13, 2021) and 1 FMD-145 letter (Sep 13, 2021) for Riverpoint Pharmacy (First Pharma Associates LLC). State board of pharmacy records for Washington are not checked: the Department of Health’s open dataset on data.wa.gov lists individual credentials but not pharmacy licenses, and its enforcement column has been removed for now; the department’s provider search is an interactive search, which this index does not use. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
First Pharma Associates LLC; Riverpoint Pharmacy
Location
Spokane, WA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
2
Warning letters on FDA’s actions page
0
Latest action on that page
Sep 13, 2021
FDA Data Dashboard inspections
1 inspection: 1 VAI; 3 published Form 483s
Form 483 text on this page
1 Form 483, 1 observation
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as First Pharma Associates LLC (dba Riverpoint Pharmacy), a 503A facility, with 5 dated actions.

Document
Sep 13, 2021State referral letterState Referral Letter Issued 9/13/2021FDA copy (archived)
Sep 13, 2021Warning letter close-outWarning Letter Close Out Issued 09/13/2021Not linked by FDA
Sep 13, 2021FMD-145 letterFMD-145 Letter Issued 09/13/2021Not linked by FDA
Mar 3, 2021Form 483483 Issued 03/03/2021FDA copy (archived)
Jun 7, 2019Form 483483 Issued 06/07/2019fda.gov

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists First Pharma Associates LLC, Spokane, WA (FEI number 3007500366), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Mar 3, 2021Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30075003661136204

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Feb 23, 2021 to Mar 3, 2021: 1 observation

Firm on the cover
First Pharma Associates LLC dba Riverpoint Pharmacy, 1802 N Monroe St, Spokane, WA 99205-4528
FEI number
3007500366
Establishment type on the cover
Producer of non-sterile drug products
FDA district office on the cover
19701 Fairchild Irvine, CA 92612-2445
Matched to this page by
FEI number on the cover; linked from actions page, Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

You produced highly potent drugs without providing adequate cleaning of utensils to prevent cross-contamination.

Specifically,

On 02 /24/21, I observed an employee perform compounding of multiple lots of non-sterile hazardous human drug products, some of which utilized product-contact metal <Redacted B4> stir axels that were cleaned with only and expired <Redacted B4> solution between lots of different products. The first hazardous compounded drug product lot manufactured at your firm on <Redacted B4> was Estradiol 0.Smg/Estriol 0.Smg/gm vaginal cream, lot 02242021@1, during which a metal stir axel was used in the blending of the in-process ointment and was in contact with the product throughout the blending process. The stir axel was cleaned using only a bottle of <Redacted B4> solution, lot # <Redacted B4> with the expiration date of 10/ 19. The same day, your firm manufactured Estriol vaginal cream 2mg/0.5mg, lot 02242021@3 in the same hazardous compounding room using potentially the same stir axel.

Linked 483s whose text is not shown

State board of pharmacy records

State board of pharmacy records for Washington are not checked: the Department of Health’s open dataset on data.wa.gov lists individual credentials but not pharmacy licenses, and its enforcement column has been removed for now; the department’s provider search is an interactive search, which this index does not use.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054019558LICENSED PHARMACYFIRST PHARMA ASSOCIATES LLCSPOKANE, WANOT RENEWED

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.